ArticleNaunyn-Schmiedeberg's archives of pharmacology2014

The ruthenium nitric oxide donor, [Ru(HEDTA)NO], inhibits acute nociception in mice by modulating oxidative stress, cytokine production and activating the cGMP/PKG/ATP-sensitive potassium channel signaling pathway.

Larissa Staurengo-Ferrari et al.PubMed ↗Publisher ↗

No numbers read from the abstract.